Literature DB >> 3701609

Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans.

C Y Lui, G L Amidon, R R Berardi, D Fleisher, C Youngberg, J B Dressman.   

Abstract

Gastrointestinal pH as a function of time was recorded for 4 beagle dogs and 10 human subjects using radiotelemetric pH measuring equipment. Results indicated that in the quiescent phase, gastric pH in the dogs (mean = 1.8 +/- 0.07 SEM) was significantly (p less than 0.05) higher than in humans (1.1 +/- 0.15). No significant difference in the time for the pH monitoring device to empty from the stomach was noted for the two species (99.8 +/- 27.2 min for dogs, 59.7 +/- 14.8 min for humans, p greater than 0.05). The fasting intestinal pH in dogs was consistently higher than in humans, with an average canine intestinal pH of 7.3 +/- 0.09 versus 6.0 +/- 0.14 for humans. The implication of these observations for extrapolation of drug absorption data from dogs to humans are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701609     DOI: 10.1002/jps.2600750313

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  33 in total

1.  Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs.

Authors:  M N Martinez; B Mistry; V Lukacova; K A Lentz; J E Polli; S W Hoag; T Dowling; R Kona; R M Fahmy
Journal:  AAPS J       Date:  2017-03-06       Impact factor: 4.009

2.  Intestinal absorption of peptides and peptide analogues: implications of fasting pancreatic serine protease levels and pH on the extent of oral absorption in dogs and humans.

Authors:  P J Sinko
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

3.  Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389.

Authors:  Sherif I Farag Badawy; David B Gray; Fang Zhao; Duxin Sun; Alan E Schuster; Munir A Hussain
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.200

4.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 5.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

6.  Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound.

Authors:  Binfeng Xia; Tycho Heimbach; Tsu-han Lin; Shoufeng Li; Hefei Zhang; Jennifer Sheng; Handan He
Journal:  AAPS PharmSciTech       Date:  2013-08-17       Impact factor: 3.246

7.  Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.

Authors:  Neil Mathias; Yan Xu; Balvinder Vig; Umesh Kestur; Amy Saari; John Crison; Divyakant Desai; Aditya Vanarase; Munir Hussain
Journal:  AAPS J       Date:  2015-05-02       Impact factor: 4.009

Review 8.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

9.  Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Authors:  Tycho Heimbach; Binfeng Xia; Tsu-han Lin; Handan He
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

10.  pH-dependent swelling and solute diffusion characteristics of poly(hydroxyethyl methacrylate-co-methacrylic acid) hydrogels.

Authors:  J H Kou; G L Amidon; P I Lee
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.